Increasing Enoxaparin Dosing from 30 mg to 40 mg Does Not Affect Bleeding or VTE Risk in Bariatric Surgery Patients

MeSH terms

• Adult
• Anticoagulants* / administration & dosage
• Anticoagulants* / adverse effects
• Bariatric Surgery* / adverse effects
• Dose-Response Relationship, Drug
• Enoxaparin* / administration & dosage
• Enoxaparin* / adverse effects
• Female
• Hemorrhage / chemically induced
• Humans
• Male
• Middle Aged
• Obesity, Morbid / surgery
• Postoperative Complications
• Retrospective Studies
• Venous Thromboembolism* / etiology
• Venous Thromboembolism* / prevention & control